nach oben

Journal of Cancer Research and Clinical Oncology

Erschienen in:

01.02.2013 | Original Paper

Overexpression of macrophage migration inhibitory factor in adenoid cystic carcinoma: correlation with enhanced metastatic potential

verfasst von: Hui Liu, Gang Chen, Wei Zhang, Jun-Yi Zhu, Zhao-Quan Lin, Zhong-Cheng Gong, Feng-Qin Wang, Jun Jia, Zhi-Jun Sun, Yi-Fang Zhao

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Adenoid cystic carcinoma (ACC) is a malignant tumor frequently arising in salivary glands with poor long-term prognosis due to high rates of local recurrences and distant metastases. Macrophage migration inhibitory factor (MIF) is a multi-functional cytokine and has recently emerged as a pro-tumorigenic factor in various cancers. This study is designed to investigate the expression status and functional significance of MIF in ACC.

Methods

Immunohistochemical staining was performed to evaluate the expression levels of MIF, HIF-1α, MMP-9, p53, and p-JNK in ACC tissues. In vitro, ACC-2 cells were exposed to recombinant human MIF (rMIF) or ISO-1 (an inhibitor of MIF) at different concentrations and times, followed by the detection of cell growth, viability, migration, and invasion, as well as the expression levels of several cellular signals.

Results

The immunohistochemical results demonstrated the overexpression of MIF in ACC tissues as well as its association with the distant metastasis. Further analyses showed a significant correlation between the staining of MIF and p-JNK. Moreover, the in vitro studies revealed that the treatment for ACC cells with ISO-1 significantly attenuated cell migratory and invasive capacity, as opposed to the limited promotive effects of rMIF. More importantly, MIF inhibition could cause the activation of JNK, correlating with the immunohistochemical findings on ACC tissues.

Conclusions

The results suggest that MIF is likely to be an important player in the pathogenesis of ACC and may promote cancer metastasis, which possibly involves JNK inactivation. Further investigation of MIF-mediated molecular events may provide novel insights into the treatment for ACC.

Nur mit Berechtigung zugänglich

Al-Abed Y, VanPatten S (2011) MIF as a disease target: ISO-I as a proof-of-concept therapeutic. Futur Med Chem 3(1):45–63CrossRef

Bach JP, Deuster O et al (2009) The role of macrophage inhibitory factor in tumorigenesis and central nervous system tumors. Cancer 115(10):2031–2040PubMedCrossRef

Balachandran S, Rodge A et al (2009) Novel derivatives of ISO-1 as potent inhibitors of MIF biological function. Bioorg Med Chem Lett 19(16):4773–4776PubMedCrossRef

Bifulco C, McDaniel K et al (2008) Tumor growth-promoting properties of macrophage migration inhibitory factor. Curr Pharm Des 14(36):3790–3801PubMedCrossRef

Bucala R, Donnelly SC (2007) Macrophage migration inhibitory factor: a probable link between inflammation and cancer. Immunity 26(3):281–285PubMedCrossRef

Chen G, Hu X et al (2012) Mammalian target of rapamycin regulates isoliquiritigenin-induced autophagic and apoptotic cell death in adenoid cystic carcinoma cells. Apoptosis 17(1):90–101PubMedCrossRef

Dodd RL, Slevin NJ (2006) Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies. Oral Oncol 42(8):759–769PubMedCrossRef

Dumitru CA, Gholaman H et al (2011) Tumor-derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation. Int J Cancer 129(4):859–869PubMedCrossRef

Fridman R, Toth M et al (2003) Cell surface association of matrix metalloproteinase-9 (gelatinase B). Cancer Metastasis Rev 22(2–3):153–166PubMedCrossRef

Heeren PA, Kloppenberg FW et al (2004) Predictive effect of p53 and p21 alteration on chemotherapy response and survival in locally advanced adenocarcinoma of the esophagus. Anticancer Res 24(4):2579–2583PubMed

Huang C, Sun Z et al (2012) Association of increased ligand cyclophilin A and receptor CD147 with hypoxia, angiogenesis, metastasis and prognosis of tongue squamous cell carcinoma. Histopathology 60(5):793–803PubMedCrossRef

Jung H, Seong HA et al (2008) Critical role of cysteine residue 81 of macrophage migration inhibitory factor (MIF) in MIF-induced inhibition of p53 activity. J Biol Chem 283(29):20383–20396PubMedCrossRef

Kleemann R, Hausser A et al (2000) Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 408(6809):211–216PubMedCrossRef

Krockenberger M, Engel JB et al (2010) Macrophage migration inhibitory factor expression in cervical cancer. J Cancer Res Clin Oncol 136(5):651–657PubMedCrossRef

Liu J, Shao C et al (2011) Molecular biology of adenoid cystic carcinoma. Head Neck. doi:10.1002/hed.21849

Lue H, Dewor M et al (2011) Activation of the JNK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on CXCR4 and CD74. Cell Signal 23(1):135–144PubMedCrossRef

Meyer-Siegler KL, Iczkowski KA et al (2006) Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells. J Immunol 177(12):8730–8739PubMed

Nabizadeh Marvast M, Sima HR et al (2011) Clinicopathological significance of macrophage migration inhibitory factor and its relation with p53 in gastric cancer. J Gastrointest Cancer 42(1):5–10PubMedCrossRef

Oda S, Oda T et al (2008) Macrophage migration inhibitory factor activates hypoxia-inducible factor in a p53-dependent manner. PLoS ONE 3(5):e2215PubMedCrossRef

Piao S, Zhao S et al (2012) Increased expression of CD147 and MMP-9 is correlated with poor prognosis of salivary duct carcinoma. J Cancer Res Clin Oncol 138(4):627–635PubMedCrossRef

Qi D, Hu X et al (2009) Cardiac macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia/reperfusion. J Clin Invest 119(12):3807–3816PubMedCrossRef

Rendon BE, Roger T et al (2007) Regulation of human lung adenocarcinoma cell migration and invasion by macrophage migration inhibitory factor. J Biol Chem 282(41):29910–29918PubMedCrossRef

Rendon BE, Willer SS et al (2009) Mechanisms of macrophage migration inhibitory factor (MIF)-dependent tumor microenvironmental adaptation. Exp Mol Pathol 86(3):180–185PubMedCrossRef

Salminen A, Kaarniranta K (2011) Control of p53 and NF-kappaB signaling by WIP1 and MIF: role in cellular senescence and organismal aging. Cell Signal 23(5):747–752PubMedCrossRef

Spiro RH (1997) Distant metastasis in adenoid cystic carcinoma of salivary origin. Am J Surg 174(5):495–498PubMedCrossRef

Sun ZJ, Chen G et al (2010a) Activation of PI3 K/Akt/IKK-alpha/NF-kappaB signaling pathway is required for the apoptosis-evasion in human salivary adenoid cystic carcinoma: its inhibition by quercetin. Apoptosis 15(7):850–863PubMedCrossRef

Sun ZJ, Chen G et al (2010b) Mammalian target of rapamycin pathway promotes tumor-induced angiogenesis in adenoid cystic carcinoma: its suppression by isoliquiritigenin through dual activation of c-Jun NH2-terminal kinase and inhibition of extracellular signal-regulated kinase. J Pharmacol Exp Ther 334(2):500–512PubMedCrossRef

Sun ZJ, Chen G et al (2011) Curcumin dually inhibits both mammalian target of rapamycin and nuclear factor-kappaB pathways through a crossed phosphatidylinositol 3-kinase/Akt/IkappaB kinase complex signaling axis in adenoid cystic carcinoma. Mol Pharmacol 79(1):106–118PubMedCrossRef

Suzuki F, Nakamaru Y et al (2005) Prognostic significance of cytoplasmic macrophage migration inhibitory factor expression in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy. Oncol Rep 13(1):59–64PubMed

Tang Y, Liang X et al (2010) Expression of c-kit and Slug correlates with invasion and metastasis of salivary adenoid cystic carcinoma. Oral Oncol 46(4):311–316PubMedCrossRef

Wagner EF, Nebreda AR (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9(8):537–549PubMedCrossRef

Winner M, Koong AC et al (2007) Amplification of tumor hypoxic responses by macrophage migration inhibitory factor-dependent hypoxia-inducible factor stabilization. Cancer Res 67(1):186–193PubMedCrossRef

Titel: Overexpression of macrophage migration inhibitory factor in adenoid cystic carcinoma: correlation with enhanced metastatic potential
verfasst von: Hui Liu
Gang Chen
Wei Zhang
Jun-Yi Zhu
Zhao-Quan Lin
Zhong-Cheng Gong
Feng-Qin Wang
Jun Jia
Zhi-Jun Sun
Yi-Fang Zhao
Publikationsdatum: 01.02.2013
Verlag: Springer-Verlag
Erschienen in: Journal of Cancer Research and Clinical Oncology / Ausgabe 2/2013
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-012-1330-z

Springer Medizin

Overexpression of macrophage migration inhibitory factor in adenoid cystic carcinoma: correlation with enhanced metastatic potential